Psoriasis as a risk factor for heart failure in adults
DOI:
https://doi.org/10.18050/revistamedicavallejiana.v11i2.02Keywords:
psoriasis, congestive heart failureAbstract
The aim of the present investigation was to demonstrate whether psoriasis is a risk factor for heart failure in adults, which was developed in adults attending the cardiology clinic of the Trujillo Regional Teaching Hospital. Material and methods. A case-control study was proposed with a sample of 744 people with a ratio of 3 controls for each case. Results: Psoriasis was present in 4% of the patients with congestive heart failure and in 1,3% of the population without congestive heart failure, finding a p= 0.031. In addition, an odds ratio of 3,08 with a 95% CI of 1,05 – 9,01 was obtained. Conclusions: The proportion of psoriasis exposure was higher in patients with heart failure compared to those without heart failure, and patients with psoriasis have two times the risk of developing congestive heart failure than those without psoriasis.
References
Manzano L. Manual práctico de manejo integral del paciente con insuficiencia cardíaca crónica. 4ª edición. Madrid: Sociedad Española de Medicina Interna; 2018.
Pereira-Rodríguez J, Rincón-González G, Niño-Serrato D. Insuficiencia cardíaca: Aspectos básicos de una epidemia en aumento. CorSalud, [Internet] 2016; 8(1): 58-70. Recuperado a partir de: http://www.revcorsalud.sld.cu/index.php/cors/ article/view/98/240
Savarese G, Lund LH. Global Public Health Burden of Heart Failure. Card Fail Rev. [Internet] 2017 Apr;3(1):7-11. Recuperado a partir de: https://www.ncbi.nlm.nih.gov/pubmed/28785469
The International Federation of psoriasis associations. Annual Report 2019. Global Psoriasis Atlas. 2019.
Eder L, Widdifield J, Rosen CF, Cook R, Lee KA, Alhusayen R, et al. Trends in the prevalence and incidence of psoriasis and psoriatic arthritis in Ontario, Canada: A population-based study. Arthritis Care Res. 2019; 71(8): 1084-91. doi: 10.1002/acr.23743
Egeberg A, Skov L, Gunnar G, Thyssen J, Mallbris L. Incidence and prevalence of psoriasis in Denmark. Acta Dermato Venereologica [Internet] 2017; 808–12. Recuperado a partir de: https://www.medicaljournals.se/acta/content/html/ 10.2340/00015555-2672
Jindal S, Jindal N. Psoriasis and cardiovascular diseases: a literature review to determine the causal relationship. Cureus. [Internet] 2018; 10(2): e2195. Recuperado a partir de: https://www.cureus.com/articles/10950-psoriasis-and-cardiovascular-diseases-a-literature-review-to-determine-the-causal-relation ship
Champs B, Degboé Y, Barnetche T. Shortterm risk of major adverse cardiovascular events or congestive heart failure in patients with psoriatic arthritis or psoriasis initiating a biological therapy: a meta–analysis of randomized controlled trials. RMD Open [Internet] 2019; 5: e000763. Recuperado a partir de: https://rmdopen.bmj.com/content/ rmdopen/5/1/e000763.full.pdf
Polachek A, Touma Z, Eider L. Risk of cardiovascular morbidity in patients with psoriatic arthritis: a meta-analysis of observational studies. Arthritis Care & Research [Internet] 2017; 69(1): 67–74. Recuperado a partir de: https://www.ncbi.nlm.nih.gov/pubmed/27111228
Parisi R, Rutter M, Lunt M, Young H, Symmons D. Griffiths C. Psoriasis and the risk of major cardiovascular events: cohort study using the clinical practice research datalink. Journal of Investigative Dermatology [Internet] 2015; 135 (9): 2189-2197. Recuperado a partir de: https://www.ncbi.nlm.nih.gov/pubmed/ 25742120
Khalid U, Ahlehoff O, Hilmar G, Lund S. Skov L, Pedersen C. Psoriasis and risk of heart failure: a nationwide cohort study European Journal of Heart Failure [Internet] 2014; 16: 743–8, Recuperado a partir de: https://online library.wiley.com/doi/pdf/10.1002/ejhf.113
Kibari A, Cohen A, Bitterman H, Shalom G, Feldhamer I, Batat E. Cardiac and cardiovascular morbidities inpatients with psoriatic arthritis: a population-based cohort study. Ann Rheum Dis [Internet] 2014; 73: 730–1. Recuperado a partir de: https://pubmed.ncbi.nlm.nih.gov/30937638/
Husted J, Thavaneswaran A, Chandran V, Cheryl L, Rosen F, Cook D. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis care & research [Internet] 2011; 63 (12): 1729-35. Recuperado a partir de: https://pubmed.ncbi.nlm.nih.gov/ 21905258/
Manzano L. Manual práctico de manejo integral del paciente con insuficiencia cardíaca crónica. 4ª edición. Madrid, Sociedad Española de Medicina Interna. 2018.
Pereira J, Rincón G, Niño D. Insuficiencia cardíaca: aspectos básicos de una epidemia en aumento. Cor Salud [Internet] 2016; 8(1): 58-70. Recuperado a partir de: http://www.revcorsalud.sld.cu/index.php/cors/article/ download/98/201
Ministerio de Sanidad, Servicios Sociales e Igualdad. Guía de Práctica Clínica sobre Tratamiento de la Insuficiencia Cardiaca Crónica. Madrid: Ministerio de Sanidad, 2016.
Villa A, Mandell B. Trastornos cardiovasculares y enfermedad reumática Rev Esp Cardiol. [Internet] 2014; 64: 809-17. Recuperado a partir de: http://www.scielo. edu.uy/scielo.php?script=sci_arttext&pid=S1688- 04202012000300011
Vilches A, Rodríguez C. Insuficiencia Cardiaca congestiva. Madrid. Sociedad Española de Geriatría y Gerontología. 2014.
Sociedad Española de Geriatría y Gerontología. Insuficiencia cardiaca congestiva. Madrid: Sociedad Española de Geriatría y Gerontología, 2014.
European Society of Cardiology. Heart failure. Prevevting disease and death worldwide. Varsovia: Global Herat Failure Awarwness Programme; [Internet] 2014. Recuperado a partir de: https://www.escardio.org/static_file/Escardio/Subspecialty/HFA/WHFA-whitepaper-15-May-14.pdf
Sociedad Europea de Cardiología. Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica. Rev Esp Cardiol. [Internet] 2016; 69(12): 1167: e1-e85. Recuperado a partir de: https://www.reves pcardiol.org/es-guia-esc-2016-sobre-el-articulo-S0300893216305541
Ziaeian B, Fonarow GC. The Prevention of hospital readmissions in heart failure. Prog Cardiovasc Dis. [Internet] 2016; 58(4): 379-85. Recuperado a partir de: https://www.revespcardiol.org/es-guia-esc-2016-sobre-el-articulo-S0300893216305541
Novartis Pharma. The handbook of multidisciplinary and integrated heart failure care Project Advisory Group; [Internet] 2018. Recuperado a partir de: https://www.hfpolicynetwork.org/wp-content/uploads/2018/09/HFPN_hand bookD_DIGITAL.pd
Ferreira J, Krausy S, Mitchellz S, Perelx P, Piñeirojj D, Chioncel O, et al. World Heart Federation Roadmap for Heart Failure. Global Heart, September [Internet] 2019; 14(3): 197-214. Recuperado a partir de: https://www.sac.org.ar/wp- content/uploads/2019/09/whf-roadmap-heart.pdf
Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Physician. [Internet] 2017; 63(4):278–285. Recuperado a partir de: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389757/
Jiménez Gómez N, Ballester Martínez MA, Pérez Gala S, Gárate Ayastuy MT. Psoriasis. Medicine. [Internet] 2014; 11: 2764-73. Recuperado a partir de: https://www.medicineonline.es/es-psoriasis-articulo-S030454121470695X
Sorensen J, Hetland ML. Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry. Ann Rheum Dis. [Internet] 2015; 74: e12 Disponible en: https://pubmed.ncbi.nlm.nih.gov/24534758/
Ortega A, Restrepo N, Úsuga R. Características epidemiológicas, clínicas e histopatológicas de pacientes con psoriasis y factores asociados con las formas vulgar y pustulosa. Dermatol Rev Mex. [Internet] 2018; 62(3): 193-205. Disponible en: https://www.medigraphic.com/pdfs/derrevmex/rmd- 2018/rmd183b.pdf
Cervantes A, Morales M, Jurado F. Epidemiology of dermatologic disorders at a referral skin center in México City. J Am Acad Dermatol. [Internet] 2015; 5(Supl 1): AB97. Disponible en: https://www.em- consulte.com/en/article/976150
Parisi R, Rutter M, Lunt M, Young H, Symmons D. Griffiths C. Psoriasis and the risk of major cardiovascular events: cohort study using the clinical practice research datalink. Journal of Investigative Dermatology [Internet] 2015; 135 (9): 2189-97. Disponible en: https://pubmed.ncbi.nlm. nih.gov/25742120/
Valenzuela F, Araya I, Correa H, De la Cruz C, Riveros T, Valdés P. Guías clínicas chilenas para el manejo de la psoriasis Rev Chil Dermatol [Internet] 2016; 32 (3): 134-49. Recuperado a partir de: https://www.rcderm.org/index.php/ rcderm/article/view/117
Takeshita J, Grewal S, Langan S, Mehta N, Ogdie A, Van Voorhees A, Psoriasis and comorbid diseases: Implications for management. J Am Acad Dermatol. [Internet] 2017 Mar;76(3):393-403. Recuperado a partir de: https://pubmed.ncbi.nlm.nih.gov/28212759/
Bhushan R, Lebwohl M, Gottlieb A, Boyer K, Hamarstrom E, Korman N. Translating psoriasis guidelines into practice: Important gaps revealed. J Am Acad Dermatol. [Internet] 2016; 74(3): 544-51. Recuperado a partir de: https://pubmed.ncbi.nlm.nih.gov/26777102/
Sociedad Argentina de Dermatología. Consenso Nacional de Psoriasis: Guía de Tratamiento 2018. Buenos Aires. Editorial Biotecnológica S.R.L. 2018.
Jindal S, Jindal N. Psoriasis and Cardiovascular Diseases: A Literature Review to Determine the Causal Relationship. Cureus. [Internet] 2018; 10(2): e2195. Recuperado a partir de: https://www.cureus.com/articles/10950-psoriasis-and-cardiovascular-diseases- a-literature-review-to-determine-the-causal-relationship
Katsiari CG, Bogdanos DP, Sakkas LI. Inflammation and cardiovascular disease. World J Transl Med [Internet] 2019; 8(1): 1-8 Recuperado a partir de: https://www.sac.org.ar/wp-content/uploads/2019/09/whf-roadmap-heart.pdf
González A, Díaz L, Chiharu S. Anzo A, García S. Generalidades de los estudios de casos y controles. Acta Pediatr Mex. [Internet] 2018; 39(1):72-80. Recuperado a partir de: https://www.medigraphic.com/pdfs/actpedmex/apm2018/apm 181h.pdf
Hernández R, Fernández P, Baptista C. Metodología de la investigación 6ª ed. Editorial Mac Graw Hill. 2017.
Aguilar J, Arriaga M, Chaves N, Zeballos D. Entendiendo la Odds Ratio. Rev Científica [Internet] 2017; 15(1): 27-30 Recuperado a partir de: http://www.revistasbolivianas.org.bo/pdf/rsscem/v15n1/v15n1_a08.pdf
Asociación Médica Mundial (AMM), Declaración de Helsinki de La Asociación Médica Mundial. Principios éticos para las investigaciones médicas en seres humanos. [Internet] 2013. Recuperado a partir de: http://www.wma.net/es/30publications/10policies/b3/17c_es.pdf
Garshick M, Ward N, Krueger J, Berger J. Cardiovascular Risk in patients with psoriasis: JACC review topic of the week. Journal of the American College of Cardiology 2021; 77(13); 1670-1680. Recuperado a partir de: https://doi.org/10.1016/j.jacc.2021.02.009
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
